NEW YORK, May 25, 2015 /PRNewswire/ -- Impressive advances in biochemistry, cell physiology and genomics have been made since the sequencing of the human genome in 2004, which provided all the genetic information carried by DNA and lead to the prevention of many diseases by analyzing the functions associated with genes. However, certain limitations appearing in the study of genes, on the reliability of the information and their lack of immediate values, bring the experts to consider other solutions.
To better understand an organism, science is becoming more and more interested in the end products of gene expression; i.e. the proteins. Proteomics science to study the proteome (set of proteins expressed by the genome of a cell, tissue or organ), facilitates the understanding, to detection and to monitoring of diseases. Proteomics is a promising and growing sector, attracting many researchers and in which numerous collaborations emerge worldwide.
Bringing new challenges such as the discovery of therapies for patients, or the acceleration of the drug development process, proteomics promises a better understanding of biological and genome complexities.
Featuring 30 companies' profiles such as Royal Philips and Agilent Technologies, and 30 R&D Laboratories such as the Department of Chemistry of Fudan University, or the Department of Pharmaceutical Sciences of the Utrecht University, this report is ideal for anyone wanting:
- Identify R&D Partners,
- Obtain IP & Technologic Intelligence,
- Develop your R&D Partnerships,
- And also benchmark competitors.
…all on a global scale.
You will also find 50 expert's profiles, containing their scientific works and details of their field of expertise.
These Key Innovation Leaders are based across the 3 main geographical areas around the globe for scientific expertise: North America (USA, Canada…), Europe (France, Germany…) and Eastern Asia (Japan, Korea, Taiwan…).
For each of them, you will receive a scientific profile updated at time of order, a selection of focused works and a presentation of their collaborative partners, as well as an in-depth explanation of why companies such as Royal Philips are leaders on Proteomics.
A Panorama is composed of:
- A global overview of the subject (issues, distribution of sources of expertise, international networks, European projects, main standards...)
- A selection of scientific profiles of actors (research centers , companies, experts)
- A selection of targeted works (from 50 different types of scientific and technical documents from more than 250 data sources).
Here are some examples of our data sources:
Research institutes databases (NASA, MIT, Fraunhofer, ...)
Patent Databases (European Patent Office, USPTO, ...)
Thematic Databases (MedLine/PubMed, INRA, ...)
Project Databases (Cordis FP-7, FP-6, ...)
Panorama are generated and updated with the unique mapping technology developed by Expernova, which covers 52 countries. Expernova data base is constantly growing, so each Panorama updated at any given time is potentially different from the others Panorama generated at other times on the same subject.
SCOPE OF THE PANORAMA
proteomic analysis, mass spectrometry, proteome, biological sample, target molecule, proteomic approach, tandem mass, complex protein mixture, proteomic data, protein interaction, hematologic malignancy, protein sample, high throughput, proteomic profile
Read the full report: http://www.reportlinker.com/p02868622-summary/view-report.html
ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001